A controlled trial of a critical pathway for treatment of community-acquired pneumonia

被引:517
作者
Marrie, TJ
Lau, CY
Wheeler, SL
Wong, CJ
Vandervoort, MK
Feagan, BG
机构
[1] John P Robarts Res Inst, London Clin Trials Res Grp, London, ON N6A 5K8, Canada
[2] Univ Alberta, Dept Med, Edmonton, AB, Canada
[3] Janssen Ortho Inc, Toronto, ON, Canada
[4] St Josephs Hlth Ctr, London, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada
[6] Ottawa Civic Hosp, Ottawa, ON K1Y 4E9, Canada
[7] London Hlth Sci Ctr, London, ON, Canada
[8] Vancouver Hosp & Hlth Sci Ctr, Vancouver, BC V5Z 1M9, Canada
[9] Cape Breton Reg Hosp, Sydney, NS, Canada
[10] Colchester Reg Hosp, Truro, NS, Canada
[11] Valley Reg Hosp, Kentville, NS, Canada
[12] Thunder Bay Reg Hosp, Thunder Bay, ON, Canada
[13] Queen Elizabeth II Hlth Sci Ctr, Halifax, NS, Canada
[14] Univ Alberta Hosp, Edmonton, AB T6G 2B7, Canada
[15] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada
[16] Hlth Sci Ctr, St Johns, NF, Canada
[17] McMaster Univ, Med Ctr, Hamilton, ON, Canada
[18] Moncton Hosp, Moncton, NB, Canada
[19] Western Reg Hlth Ctr, Yarmouth, NS, Canada
[20] Hlth Serv Assoc S Shore, Bridgewater, NS, Canada
[21] Royal Columbian Hosp, New Westminster, BC, Canada
[22] London Clin Trials Grp, London, ON, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2000年 / 283卷 / 06期
关键词
D O I
10.1001/jama.283.6.749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Large variations exist among hospitals in the use of treatment resources for community-acquired pneumonia (CAP). Lack of a common approach to the diagnosis and treatment of CAP has been cited as an explanation for these variations. Objective To determine if use of a critical pathway improves the efficiency of treatment for CAP without compromising the well-being of patients. Design Multicenter controlled clinical trial with cluster randomization and up to 6 weeks of follow-up. Setting Nineteen teaching and community hospitals in Canada. Patients A total of 1743 patients with CAP presenting to the emergency departmental 1 of the participating institutions between January 1 and July 31, 1998. Intervention Hospitals were assigned to continue conventional management (n = 10) or implement the critical pathway (n = 9), which consisted of a clinical prediction rule to guide the admission decision, levofloxacin therapy, and practice guidelines. Main Outcome Measures Effectiveness of the critical pathway, as measured by health-related quality of life on the Short-Form 36 Physical Component Summary (SF-36 PCS) scale at 6 weeks; and resource utilization, as measured by the number of bed days per patient managed (BDPM). Results Quality of life and the occurrence of complications, readmission, and mortality were not different for the 2 strategies; the 1-sided 95% confidence limit of the between-group difference in the SF-36 PCS change score was 2.4 points, which was within a predefined 3-point boundary for equivalence. Pathway use was associated with a 1.7-day reduction in BDPM (4.4 vs 6.1 days; P = .04) and an 18% decrease in the admission of low-risk patients (31 % vs 49 %; P = .01). Although inpatients at critical pathway hospitals had more severe disease, they required 1.7 fewer days of intravenous therapy (4.6 vs 6.3 days; P = .01) and were more likely to receive treatment with a single class of antibiotic (64% vs 27%; P < .001). Conclusion In this study, implementation of a critical pathway reduced the use of institutional resources without causing adverse effects on the well-being of patients.
引用
收藏
页码:749 / 755
页数:7
相关论文
共 35 条
[1]   COMMUNITY-ACQUIRED PNEUMONIA [J].
BARTLETT, JG ;
MUNDY, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) :1618-1624
[2]   Community-acquired pneumonia [J].
Brown, PD ;
Lerner, SA .
LANCET, 1998, 352 (9136) :1295-1302
[3]  
*CDCP, 1997, 1994 NAT HOSP DISCH, V13
[4]   BREAKING THE MATCHES IN A PAIRED T-TEST FOR COMMUNITY INTERVENTIONS WHEN THE NUMBER OF PAIRS IS SMALL [J].
DIEHR, P ;
MARTIN, DC ;
KOEPSELL, T ;
CHEADLE, A .
STATISTICS IN MEDICINE, 1995, 14 (13) :1491-1504
[5]   Statistical considerations in the design and analysis of community intervention trials [J].
Donner, A ;
Klar, N .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1996, 49 (04) :435-439
[6]   A METHODOLOGICAL REVIEW OF NON-THERAPEUTIC INTERVENTION TRIALS EMPLOYING CLUSTER RANDOMIZATION, 1979-1989 [J].
DONNER, A ;
BROWN, KS ;
BRASHER, P .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1990, 19 (04) :795-800
[7]   Evidence-based disease management [J].
Ellrodt, G ;
Cook, DJ ;
Lee, J ;
Cho, M ;
Hunt, D ;
Weingarten, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (20) :1687-1692
[8]  
Falconer J A, 1993, QRB Qual Rev Bull, V19, P8
[9]   A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia [J].
File, TM ;
Segreti, J ;
Dunbar, L ;
Player, R ;
Kohler, R ;
Williams, RR ;
Kojak, C ;
Rubin, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (09) :1965-1972
[10]   Prognosis and outcomes of patients with community-acquired pneumonia - A meta-analysis [J].
Fine, MJ ;
Smith, MA ;
Carson, CA ;
Mutha, SS ;
Sankey, SS ;
Weissfeld, LA ;
Kapoor, WN .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :134-141